Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis. [PDF]
Berczi AS +5 more
europepmc +1 more source
Case Report: Biweekly TAS-102 and bevacizumab as maintenance therapy for recurrent and metastatic pseudomyxoma peritonei following palliative cytoreduction. [PDF]
Wang B +6 more
europepmc +1 more source
The Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis). [PDF]
Spiliotis J +6 more
europepmc +1 more source
Hepatic resection for ovarian cancer in Germany: a nationwide epidemiological study based on DRG (diagnosis-related groups) data (2020-2024). [PDF]
Acs M +8 more
europepmc +1 more source
Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis. [PDF]
Braun C, Peikert J, Brambs C.
europepmc +1 more source
A Narrative Review of Clinical and Molecular Criteria for the Selection of Poor Candidates for Optimal Cytoreduction in Epithelial Ovarian Cancer. [PDF]
Pariza G +4 more
europepmc +1 more source
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors. [PDF]
Chang J, Grewal US, Sherman SK, Howe JR.
europepmc +1 more source
Giant Chest Wall Metastasis of Rectal Adenocarcinoma with Multistructural Involvement. [PDF]
Murawa D +6 more
europepmc +1 more source
Artificial intelligence for precision management of epithelial ovarian cancer: a comprehensive review. [PDF]
Liu Q +5 more
europepmc +1 more source
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC): an initial experience at a Tertiary care Hospital in Pakistan. [PDF]
Aimon S, Khan HM, Khan U, Atiq M.
europepmc +1 more source

